OLR1 and atherosclerosis: Regarding miR-186-5p, a previous study indicates that serum exosomal miR-186-5p shows a good diagnostic performance for AMI, and its dysregulation in exosomes contributes to atherosclerosis by targeting lectin-like ox-LDL receptor-1 (LOX-1) (15).